[Hemotherapy in malignant hematologic diseases].
Schweiz Med Wochenschr, 1975/6/14;105(24):778-9.
PMID: 49923
Abstract
For the majority of patients with malignant blood diseases the ideal transfusion products are blood components instead of whole blood. The therapeutic use of packed red cells, platelets, leukocytes and albumin is briefly discussed.
MeSH terms
Antigen-Antibody Reactions; Blood Platelets; Blood Transfusion; Erythrocytes; Fibrinogen; Histocompatibility Antigens; Humans; Leukemia; Leukocytes; Serum Albumin; gamma-Globulins
More resources
EndNote: Download